You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 6, June 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (67)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dementias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Frontotemporal Lobar Degeneration

Demographic Characteristics of 353 Patients

Julene K. Johnson, PhD; Janine Diehl, MD; Mario F. Mendez, MD, PhD; John Neuhaus, PhD; Jill S. Shapira, RN, PhD; Mark Forman, MD, PhD; Dennis J. Chute, MD; Erik D. Roberson, MD, PhD; Catherine Pace-Savitsky, MA; Manuela Neumann, MD; Tiffany W. Chow, MD; Howard J. Rosen, MD; Hans Forstl, MD; Alexander Kurz, MD; Bruce L. Miller, MD

Arch Neurol. 2005;62:925-930.

Background  Until recently, frontotemporal lobar degeneration (FTLD) was considered a rare neurodegenerative disorder that was difficult to diagnose. The publication of consensus criteria for FTLD, however, prompted systematic studies. The criteria categorize FTLD into 3 subgroups: frontotemporal dementia, semantic dementia, and progressive nonfluent aphasia.

Objective  To compare demographic characteristics of patients in the 3 FTLD subgroups.

Design  We compared diagnostic breakdown, age at onset, sex, Mini-Mental State Examination score at first visit, education, and neuropathological diagnoses in a large sample of FTLD patients from 3 different university dementia clinics, including 2 neurologic clinics in the United States and 1 psychiatric clinic in Germany.

Results  The frontotemporal dementia subgroup represented approximately half of all FTLD diagnoses. Patients diagnosed as having frontotemporal dementia (mean age, 57.5 years) and semantic dementia (mean age, 59.3 years) had an earlier age at onset than patients diagnosed as having progressive nonfluent aphasia (mean age, 63.0 years). There were significantly more men diagnosed as having frontotemporal dementia (63.5%) and semantic dementia (66.7%) when compared with progressive nonfluent aphasia (39.1%) (P = .005 for frontotemporal dementia vs progressive nonfluent aphasia and P = .002 for semantic dementia vs progressive nonfluent aphasia). Generally, the demographic features and diagnostic categories of the patient populations across the 3 sites were comparable. There were 68 deaths and 37 autopsies. Frontotemporal lobar degeneration with ubiquitin-positive {tau}-negative inclusions (48.5%), dementia lacking distinctive histopathological features (18.2%), and Pick disease (15.2%) were the most common neuropathological diagnoses.

Conclusions  These findings show that cohorts of patients can be combined using new research criteria for FTLD and demonstrate striking demographic differences among FTLD subgroups. The sex and age-at-onset differences suggest that there may be biological differences among FTLD subgroups. In this sample, FTLD with ubiquitin-positive inclusions accounted for half of all neuropathological diagnoses.


Author Affiliations: Departments of Neurology (Drs Johnson, Roberson, Rosen, and Miller and Ms Pace-Savitsky) and Biostatistics (Dr Neuhaus) and Gladstone Institute of Neurological Disease (Dr Roberson), University of California, San Francisco; Technische Universität Munich, Munich, Germany (Drs Diehl, Forstl, and Kurz); Departments of Neurology (Drs Mendez and Shapira) and Pathology and Laboratory Medicine (Dr Chute), University of California, Los Angeles; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia (Dr Forman); Center for Neuropathology and Prion Research, Ludwig Maximilians University, Munich (Dr Neumann); and The Rotman Research Institute of Baycrest Centre for Geriatric Care, University of Toronto, Toronto, Ontario (Dr Chow).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A new subtype of frontotemporal lobar degeneration with FUS pathology
Neumann et al.
Brain 2009;132:2922-2931.
ABSTRACT | FULL TEXT  

TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Steinacker et al.
Arch Neurol 2008;65:1481-1487.
ABSTRACT | FULL TEXT  

Distinct genetic forms of frontotemporal dementia
Seelaar et al.
Neurology 2008;71:1220-1226.
ABSTRACT | FULL TEXT  

Measuring progression in frontotemporal dementia: Implications for therapeutic interventions
Kipps et al.
Neurology 2008;70:2046-2052.
ABSTRACT | FULL TEXT  

An Evidence-Based Review of the Psychopathology of Frontotemporal Dementia: A Report of the ANPA Committee on Research
Mendez et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:130-149.
ABSTRACT | FULL TEXT  

Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions
Mackenzie et al.
Brain 2008;131:1282-1293.
ABSTRACT | FULL TEXT  

TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis
Neumann et al.
Arch Neurol 2007;64:1388-1394.
ABSTRACT | FULL TEXT  

Clinicopathologic correlation in PGRN mutations
Davion et al.
Neurology 2007;69:1113-1121.
ABSTRACT | FULL TEXT  

Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive Impairment
Whitwell et al.
Arch Neurol 2007;64:1130-1138.
ABSTRACT | FULL TEXT  

TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations
Seelaar et al.
Brain 2007;130:1375-1385.
ABSTRACT | FULL TEXT  

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.
Ber et al.
Brain 2006;129:3051-3065.
ABSTRACT | FULL TEXT  

The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
Mackenzie et al.
Brain 2006;129:3081-3090.
ABSTRACT | FULL TEXT  

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Neumann et al.
Science 2006;314:130-133.
ABSTRACT | FULL TEXT  

Pathological Heterogeneity of Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions Delineated by Ubiquitin Immunohistochemistry and Novel Monoclonal Antibodies
Sampathu et al.
Am. J. Pathol. 2006;169:1343-1352.
ABSTRACT | FULL TEXT  

Self-conscious emotion deficits in frontotemporal lobar degeneration
Sturm et al.
Brain 2006;129:2508-2516.
ABSTRACT | FULL TEXT  

A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD
van der Zee et al.
Brain 2006;129:841-852.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.